Options for improving effectiveness of rotavirus vaccines in developing countries

• Egile Nagusiak: Marion S. Tissera (Egilea), Daniel Cowley (Egilea), Nada Bogdanovic-Sakran (Egilea), Melanie L. Hutton (Egilea), Dena Lyras (Egilea), Carl D. Kirkwood (Egilea), Jim P. Buttery (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2017-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Rotavirus gastroenteritis is a leading global cause of mortality and morbidity in young children due to diarrhea and dehydration. Over 85% of deaths occur in developing countries. In industrialised countries, 2 live oral rotavirus vaccines licensed in 2006 quickly demonstrated high effectiveness, dr...